CD4+ and CD8+ T cells from the healthy donors (stimulated with CMV pp65 or autologous LCL) and melanoma patient A02 (stimulated with the autologous melanoma cell line) cloned at comparable efficiencies (26-47% of all wells grew). The gene discussed is CD8A; the disease is melanoma.